Genetic

Early Detection of Congenital Ventriculomegaly: Preventing Developmental Disabilities

by

New research published in Science Translational Medicine indicates that congenital cerebral ventriculomegaly (CCV)—a condition marked by fluid-filled brain ventricle swelling—is frequently linked to rare, damaging gene mutations. According to investigators at the Mass General Brigham Neuroscience Institute, these genetic findings suggest that CCV is often a marker of underlying neurodevelopmental disorders, including autism spectrum disorder, … Read more

Modern IVF: Higher Live Birth Rates and Fewer Twin Pregnancies

by

Modern IVF treatments now achieve a 68.2% cumulative live birth rate over three cycles while maintaining a multiple birth rate of just 2.9%, according to research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE). This represents a significant improvement over historical methods that often resulted in multiple … Read more

Why Rare Leukemia Patients Develop Tagraxofusp Resistance: New Study Findings

by

Researchers at The University of Texas MD Anderson Cancer Center have identified that resistance to tagraxofusp in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) is driven by severe mutations in the TET2 gene and reduced expression of the TXNRD1 enzyme. Published in the journal Leukemia, the study provides a potential framework for using these … Read more

Space Travel and Aging: How Liver Changes Unlock New Clues

by

Exposure to space radiation and microgravity triggers rapid genetic changes in the liver that mirror the human aging process, according to research published in the journal GeroScience. How does space travel accelerate the aging process? Space environments force the human body to endure conditions that trigger premature biological decline. Michal Masternak, a professor of medicine … Read more

New Molecular Mechanism Linked to Inherited Heart Disease

by

Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new molecular mechanism driving hypertrophic cardiomyopathy, the most common inherited heart disease. A study published in Nature Cardiovascular Research confirms that the targeted therapy mavacamten remains effective across various genetic mutations, potentially expanding treatment options for the estimated 95,230 patients living with the … Read more

AI Reveals Hidden Molecular Signals Boosting Thrombosis Risk

by

Researchers from the Sant Pau Research Institute (IR Sant Pau) and CIBERER have developed an AI tool that identifies hundreds of molecular signals to predict venous thrombosis. By integrating clinical, genetic, and transcriptomic data, the system improves risk stratification for idiopathic venous thromboembolism, as detailed in the Journal of Thrombosis and Haemostasis. Why do some … Read more

New Experimental Drug Protects Nerve Cells From ALS Damage

by

University of Arizona researchers have developed an experimental drug, XL20, that shows potential to protect nerve cells from damage associated with amyotrophic lateral sclerosis (ALS). According to a study published in Nature Aging, the drug targets a specific region of the TDP-43 protein to prevent toxic clumping, a process that contributes to neurodegeneration in ALS … Read more

Reviving Vancomycin: Groundbreaking Strategy Shows Promise Against Resistant Bacteria

by

Breakthrough in Antibiotic Resistance: Targeting Bacterial Enzymes How the Study Uncovered a New Approach Antibiotic resistance, a global health crisis linked to 4.7 million deaths in 2019, has seen a critical breakthrough. Researchers at Scripps Research discovered that disabling a bacterial enzyme called secreted antigen A (SagA) makes vancomycin-resistant Enterococcus faecium (VREfm) vulnerable to vancomycin. … Read more

Breastfeeding for Six Months Linked to Lower ADHD Risk

by

Exclusive breastfeeding for up to six months is associated with a lower risk of ADHD symptoms in children between the ages of three and eight, according to a study published in Biological Psychiatry. Researchers from the University of Bergen analyzed data from 37,600 families in the Norwegian Mother, Father and Child Cohort Study (MoBa) to … Read more

High-Dose DHA Fails to Boost Memory Despite Brain Penetration

by

High-dose docosahexaenoic acid (DHA) supplementation successfully increases omega-3 levels in the human brain but fails to halt cognitive decline or structural brain changes, according to a randomized clinical trial published in eBioMedicine. Researchers monitored 365 older adults over two years, finding that while the supplement reached the central nervous system, it provided no measurable benefit … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com